| |
|
|
|
|
|
|
|||
|
CORRESPONDENCE A 56-year-old male patient was admitted to our intensive care
unit (ICU) because of sepsis with multiple organ failure. Twelve days
before admission, the patient underwent adjuvant renal instillation of
bacillus Calmette-Guérin (BCG), an attenuated strain of
Mycobacterium bovis, after subtotal resection of
the right renal pelvis due to papillary transitional cell carcinoma.
Bone marrow aspiration revealed multiple epitheloid-cell granulomas
with central necrosis, and a positive polymerase chain reaction
(PCR) for Mycobacterium tuberculosis complex was
found in the tracheobronchial secretion. Diagnosis of BCG sepsis was
made. Despite extensive and adequate therapy, multiple organ failure
persisted and the patient died after 35 days in the ICU. On
autopsy, multiple epitheloid-cell granulomas with central necrosis were
found in the spleen, bone marrow, and lungs. Serial blood samples were collected during the first 5 days in the ICU,
in order to evaluate levels of tumor necrosis factor- Instillation of BCG is used to enhance the cytotoxic activity by
natural killer (NK) cells and cytotoxic T (CTL) cells against transitional cancer cells.1,2 Upon stimulation with BCG, macrophages produce IL-12 and TNF- In our patient, elevated plasma levels of IL-12, INF- Upon microbial stimulation, patients with a IL-12 receptor deficiency
are unable to generate sufficient amounts of IFN- Sepsis as a severe but rare complication of BCG-instillation therapy occurs in 0.4% of treated patients.1 We show for the first time that, once in systemic circulation, BCG systemically activates and enhances NK- and CTL-cell-mediated cytotoxicity and, therefore, might contribute to the development of multiple organ failure and, hence, to fatal outcome.
Sacha Zeerleder, C. Erik Hack, Christoph Caliezi, Renate Hebeisen, and Walter A. Wuillemin Supported by a grant from the Swiss National Foundation for Scientific Research (no. 32-55312.98) and by an unrestricted grant from Aventis Behring Switzerland. References 1. Mungan NA, Witjes JA. Bacille Calmette-Guérin in superficial transitional cell carcinoma. Br J Urol. 1998;82:213-223[Medline] [Order article via Infotrieve]. 2. Schamhart DHJ, de Boer EC, de Reijke TM, Kurth KH. Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: their practical use. Eur Urol. 2000;37(suppl 3):16-23. 3. Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases. Clin Microbiol Rev. 1997;10:611-636[Abstract].
4.
Altare F, Durandy A, Lammas D, et al.
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
Science.
1998;280:1432-1435
5.
Jouanguy E, Altare F, Lamhamedi S, et al.
Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.
N Engl J Med.
1996;335:1956-1961
6.
Carson WE, Yu H, Dierksheide J, et al.
A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells.
J Immunol.
1999;162:4943-4951
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||